World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1041)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series.

Item

Count

PDF

HTML

615

Figures (1-3)

160

Sum=808

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

134

Sum=186

Jul 24, 2024 (publication date) through Jan 28, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Peng GQ, Song HC, Chen WY. Concomitant epidermal growth factor receptor mutation/c-ros oncogene 1 rearrangement in non-small cell lung cancer: A case report. World J Clin Oncol 2024; 15(7): 945-952 [PMID: 39071469 DOI: 10.5306/wjco.v15.i7.945]
URL:	https://www.wjgnet.com/2218-4333/full/v15/i7/945.htm

Number	Citing Articles
1	Yan Zhou, Bo-Tao Xu, Hai-Ying Zhou, Zhong-Tu Shang. Therapeutic insights into epidermal growth factor receptor/reactive oxygen species proto-oncogene 1-receptor co-mutated non-small cell lung cancer: Crizotinib as a promising option. World Journal of Clinical Oncology 2025; 16(3): 103297 doi: 10.5306/wjco.v16.i3.103297 Abstract(16) \| Core Tip(14) \| Full Article(HTML)(59) \| Full Article with Cover (PDF)-523K(5) \| Audio-409K(2) \| Peer-Review Report-438K(6) \| Answering Reviewers-207K(6) \| Full Article (PDF)-355K(6) \| Full Article (XML)-48K(6) \| Times Cited (0) \| Total Visits (186) \| Open

Number

Citing Articles

Yan Zhou, Bo-Tao Xu, Hai-Ying Zhou, Zhong-Tu Shang. Therapeutic insights into epidermal growth factor receptor/reactive oxygen species proto-oncogene 1-receptor co-mutated non-small cell lung cancer: Crizotinib as a promising option. World Journal of Clinical Oncology 2025; 16(3): 103297 doi: 10.5306/wjco.v16.i3.103297